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Abstract 
Background: Insecticides are still at the core of insect pest and vector control programmes. Several lines of evidence 
indicate that ABC transporters are involved in detoxification processes against insecticides, including permethrin and 
other pyrethroids. In particular, the ABCG4 gene, a member of the G subfamily, has consistently been shown to be 
up-regulated in response to insecticide treatments in the mosquito malaria vector Anopheles stephensi (both adults 
and larvae).
Methods: To verify the actual involvement of this transmembrane protein in the detoxification process of perme-
thrin, bioassays on larvae of An. stephensi, combining the insecticide with a siRNA, specifically designed for the inhibi-
tion of ABCG4 gene expression were performed. Administration to larvae of the same siRNA, labeled with a fluores-
cent molecule, was effected to investigate the systemic distribution of the inhibitory RNA into the larval bodies. Based 
on siRNA results, similar experiments using antisense Vivo-Morpholinos (Vivo-MOs) were effected. These molecules, 
compared to siRNA, are expected to guarantee a higher stability in environmental conditions and in the insect gut, 
and present thus a higher potential for future in-field applications.
Results: Bioassays using two different concentrations of siRNA, associated with permethrin, led to an increase of 
larval mortality, compared with results with permethrin alone. These outcomes confirm that ABCG4 transporter plays 
a role in the detoxification process against the selected insecticide. Moreover, after fluorescent labelling, it was shown 
the systemic dissemination of siRNA in different body districts of An. stephensi larvae, which suggest a potential sys-
temic effect of the molecule. At the same time, results of Vivo-MO experiments were congruent with those obtained 
using siRNA, thus confirming the potential of ABCG4 inhibition as a strategy to increase permethrin susceptibility in 
mosquitoes. For the first time, Vivo-MOs were administered in water to larvae, with evidence for a biological effect.
Conclusions: Targeting ABCG4 gene for silencing through both techniques resulted in an increased pyrethroid 
efficacy. These results open the way toward the possibility to exploit ABCG4 inhibition in the context of integrated 
programmes for the control An. stephensi mosquitoes and malaria transmission.
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Background
Vector-borne diseases are among the main public 
health threats in the world. According to the WHO, 216 
million cases of malaria and 445,000 deaths occurred 
in 2016 [1]. Although great results in malaria control 
have been achieved in the past decades, the occurrence 
of drug resistance in Plasmodium falciparum, in par-
ticular against artemisinin and other drugs [2–7], and 
insecticide resistance in mosquito populations [1, 8–
11] are threatening the efforts for an effective control of 
the disease. Insecticides remain the core of all malaria 
control programmes, despite the diffusion of resistant 
vector mosquitoes, caused by their heavy use. Pyre-
throids, and permethrin in particular, are widely used 
for indoor residual spraying (IRS) and for the treat-
ment of bed nets. As such, it is of pivotal importance 
to understand the molecular mechanisms of detoxi-
fication in mosquitoes, both in sensitive and resistant 
populations/strains. This knowledge could lead to the 
development of strategies aimed to restore sensitivity 
in resistant populations and to avoid the evolution of 
resistances in sensitive ones [12–17].
Several studies, carried out over the years, have iden-
tified a number of genes involved in the detoxification 
of xenobiotics in mosquitoes, such as Glutathione-S-
transferase (GSTs) [18–22], Epsilon glutathione trans-
ferase (GSTe) [23], Cytochromes P450 (CYPs) [22], 
Acetylcholinesterase (AChE1) [24] and ATP Binding 
Cassette (ABC) transporters [17, 25–29]. Among these, 
in particular, the ABCG4 transporter, belonging to the 
G subfamily of ABCs, has consistently been shown to 
be up-regulated in response to permethrin treatment, 
suggesting an important role in detoxification against 
this insecticide in Anopheles stephensi larvae [22, 25, 
26] and adults [28]. A first aim of this study was thus 
to verify whether the ABCG4 efflux pump plays a role 
in permethrin detoxification in An. stephensi. To this 
purpose, assays using siRNAs targeted on the ABCG4 
mRNA, were performed to determine whether the inhi-
bition of the expression of this gene increases suscepti-
bility to permethrin.
It was emphasized that down-regulation through RNA 
interference (RNAi) has been achieved for various detoxi-
fication genes, inducing an increase of mosquito sensitiv-
ity to different classes of insecticides [14, 30, 31], but this 
technique has also been used for identifying new resist-
ance candidate genes [32]. RNAi-based tools have also 
been tested for their biopesticide potential [33] and as 
sterility inducer [34]. These results highlight the potential 
of RNAi as a promising research tool towards the devel-
opment of novel strategies in vector control. Thus, RNAi-
based tools hold potential for possible field applications 
as larvicides [35].
As stated by the WHO, the larval source manage-
ment (LSM) still represents the backbone of integrated 
mosquito control programmes, with a large-scale effec-
tiveness, able to complement measures against adult 
mosquitoes and limit the residual transmission of 
malaria [36, 37]. In this backdrop, oligonucleotides for 
gene expression inhibition, like siRNA for RNAi, gained 
importance as a potential novel class of ecofriendly lar-
vicides, which can target both insecticide-resistant 
and-sensible vectors [14, 30, 35]. However, the duration 
of activity of these molecules and their stability (persis-
tence) in the field, such as the external water environ-
ment and the inner organism of the target larvae, has still 
to be checked [38, 39]. The “oral delivery” of dsRNA to 
Anopheles mosquito larvae, while demonstrating also a 
systemic knockdown effect of target genes [30], implies 
a partial degradation of the RNA oligonucleotides in the 
insect gut [40] and a decrease in their effect [41].
Another antisense gene knockdown technology is the 
antisense Morpholino (MO), which is based on the action 
of uncharged molecules able to induce a complementary-
based block mRNA translation into protein without 
degradation of mRNA [39, 42]. The use of these oligo-
nucleotides has achieved excellent results in applications 
requiring an extreme specificity in complex systems (e.g. 
embryo development) [39]. These highly stable synthetic 
oligonucleotides can be also conjugated with a delivery 
moiety, allowing cell-penetration and the in vivo-uptake. 
These conjugated molecules, Vivo-Morpholinos (Vivo-
MOs), have already been used in cell culture treatment, 
or in studies in vivo through microinjection [43, 44], elec-
troporation and also through oral administration [45], 
and bath-immersion [46, 47]. A recent study performed 
on adult of An. stephensi underlined the suitability of 
Vivo-MO oral delivery as an efficient method for gene 
knockdown in mosquitoes [41]. For this reason, in the 
present work the second aim was to confirm the potential 
of Vivo-MO through administration in water to larvae, 
verifying the biological effects (larval mortality) and the 
effects on gene expression.
Methods
Mosquito breeding
Eggs derived from a colony of a susceptible strain of mos-
quitoes, An. stephensi Liston strain, are obtained from the 
insectarium of the University of Camerino, Italy. In this 
colony, adult and larvae of mosquitoes are reared with a 
12:12 light–dark photoperiod, following standard condi-
tion of temperature and humidity: 28 ± 1 °C and 85–90% 
relative humidity, 5% sucrose solution feeding. Eggs are 
put into well water for hatching and larvae are fed daily 
with fish food (TetraFish, Melle, Germany), following the 
same standard conditions of the insectary.
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Specific siRNA design
Two 25nt Stealth RNAi™ siRNA sequences (5′ UCU ACA 
CAC UGU ACU GGC UCA UGU A 3′; 5′ UUU AUC ACU 
CAU CCG AUA UGC CAG G 3′) were designed using the 
online software BLOCK-IT™ RNAi Designer (Thermo 
Fisher Scientific, Waltham, Massachusetts, U.S.), with 
high complementarity to the ABCG4 mRNA available 
sequence of An. stephensi (EMBL accession number: 
LK392617.1). A scrambled sequence of each siRNA (5′ 
AUA GCC ACA GUG UUA UCU CUU CAC G 3′; 5′ GGA 
AUA CGU GUU ACC GCA AUU AGA G 3′) without homol-
ogy to any An. stephensi gene has been used as control. 
Two different siRNAs were administered in order to 
determine which one was more effective, according to 
the supplier indications. 5′ UCU ACA CAC UGU ACU 
GGC UCA UGU A 3′ (and relative scramble) was identi-
fied as the most effective (data not shown), thus used for 
further experiments.
ABCG4 gene silencing in larvae of mosquitoes using siRNA
Treatments with siRNA through oral delivery were per-
formed on the third instar larvae. Groups of 50 third 
instar larvae were soaked in a volume of 357  μl siRNA, 
or scrambled siRNA, at two different concentrations 
(0.03  μg/μl and 0.06  μg/μl) in RNase-free water, to pre-
vent siRNA degradation. The lowest concentration was 
selected because previously used by Figueira-Mansur 
et al. [14] on Aedes aegypti larvae. Additional groups of 
50 larvae were treated only with RNase-free water as a 
control. This step was performed for 3  h, and fish food 
(TetraFish, Melle, Germany) was administered to all 
groups. The 3-h exposure time was determined in a pre-
liminary experiment, soaking An. stephensi third instar 
larvae in 0.5% bromophenol blue according to the proto-
col described in [31]. At the end of the treatment, each 
group of larvae was gently transferred in 100 ml of well 
water and an  LD50 dose of permethrin (0.072  mg/l) has 
been added to all groups, except the two control groups 
[48]. Before the administration, the powdered insecti-
cide was dissolved in acetone and then diluted in water to 
obtain the test solutions; the  LD50 and the sub-lethal dose 
of permethrin (i.e. the dose at which no dead larvae were 
observed) were determined using different concentra-
tions, as reported in Epis et al. [25]. All the experiments 
were performed three times.
Gene expression analysis in larvae treated with siRNA
After six and 24 h of permethrin exposure, pools of 5 sur-
viving individuals (able to move through the water col-
umn) were put in extraction buffer + β-mercaptoethanol 
for immediate RNA extraction using the commer-
cial RNeasy Mini Kit (Qiagen, Hilden, Germany) with 
an additional on-column DNase I treatment (Qia-
gen, Hilden, Germany), according to the manufactur-
er’s instructions. RNA concentration was determined 
by Qubit 3.0 Fluorometer (Thermo Fisher Scientific, 
Waltham, Massachusetts, U.S.). cDNAs were synthesized 
starting from 200  ng of total RNA, using a QuantiTect 
Reverse Transcription Kit (Qiagen, Hilden, Germany) 
with random hexamers. cDNA was used as template in 
RT-qPCR reaction, using ABCG4 primers, already pub-
lished in previous works [25, 26]. Two endogenous ref-
erence genes for An. sthephensi were used to obtain 
a normalization of data: rps7 [49] and GAPDH [50] 
(Table 1). Gene relative expression was determined using 
a BioRad iQ5 Real-Time PCR Detection System (Bio-Rad, 
California, USA). The analysis was carried out in accord-
ance with the following conditions: 50 ng cDNA; 300 nM 
of forward and reverse primers; 98  °C for 30″, 40 cycles 
of 98 °C for 15″, 59 °C for 30″, 72 °C for 30″; fluorescence 
acquisition at the end of each cycle; melting curve analy-
sis after the last cycle. Cq values were determined for 
each gene, in order to calculate gene expression levels 
of target gene using rps7 and GAPDH as internal refer-
ence genes. The expression level of ABCG4 in the control 
group was considered as basal level, in order to evaluate 
the effect of permethrin induction and RNAi effect. The 
estimates of the expression level of ABCG4 in the siRNA- 
treated and scramble-treated larvae are reported as 
means between different pools ± standard deviation (SD).
Mortality bioassay on larvae treated with ABCG4 siRNA
In order to estimate the mortality of larvae, induced by 
the combined treatment of permethrin and siRNA, a spe-
cific bioassay was performed. Briefly, groups of 25 larvae 
were soaked in 178 μl of siRNA or scrambled siRNA at 
a concentration of 0.03  μg/μl and 0.06  μg/μl in RNase 
free water. Groups of larvae were treated with siRNA or 
scramble siRNA, while additional groups were treated 
only with water. After 3  h of treatment each group was 
gently transferred into 100 ml of well water plus an  LD50 
Table 1 Primer sequences of ABC transporters and housekeeping genes of Anopheles stephensi 
Gene Forward primer Reverse primer bp Sources
AnstABCG4 ATG AGC CCA TTC GTC CTG AGC GTG GAG AAG AAG CAG 158 [25]
rps7 AGC AGC AGC AGC ACT TGA TTTG TAA ACG GCT TTC TGC GTC ACCC 90 [49]
GAPDH GCC GTC GGC AAG GTC ATC CC TTC ATC GGT CCG TTG GCG GC 166 [50]
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of permethrin (0.072 mg/l), previously determinate with 
other bioassays with different insecticide concentra-
tion. Groups of 25 larvae soaked in just water were used 
as control. Mortality was assessed after 6 h and 24 h of 
permethrin exposure and larvae were considered dead if 
static, even after a mechanical stimulus [48].
Systemic dissemination of siRNA
To verify if the ABCG4 siRNA was able to be absorbed 
into the larva (in particular into the midgut) third instar 
larvae were soaked for 3  h in the higher concentration 
(0.06 μg/μl) of the same ABCG4 siRNA, conjugated with 
Alexa Fluor 488 (Thermo Fisher Scientific, Waltham, 
Massachusetts, U.S.). The diffusion of the fluorescent sig-
nal was analysed by Zeiss Axio Zoom.V16 stereo micro-
scope after 3 h and 24 h of siRNA exposure.
Specific Vivo‑Morpholino design
An ABCG4 Vivo-Morpholino (AnstMO_ABCG4; Gene-
Tools LLC, Philomath, OR, USA) was designed using the 
Tool of GeneTools LLC company and it was comprised 
of a Morpholino conjugated to a transporter structure/
delivery moiety, comprised of an octa-guanidine den-
drimer, that improves uptake of the oligonucleotides 
by cells in tissues [51]. The sequence (5′ ATG CTC TAG 
CTT CTC GCA CAC CAA A 3′) of the Vivo-Morpholino 
AnstMO_ABCG4 was designed with high complemen-
tarity to the ABCG4 mRNA sequence of An. stephensi 
(accession number LK392617.1) following the suggestion 
of the manufacturers. As for the siRNA, the Vivo-Mor-
pholino AnstMO_ABCG4 was administered at the third 
instar larvae [48] in nuclease free water.
ABCG4 gene silencing in larvae of mosquitoes using 
Morpholino
This is the first study where the Vivo-Morpholino oligo-
nucleotides has been used against mosquito larvae; for 
this reason, the experimental procedure for oral admin-
istration through bath immersion were performed fol-
lowing the protocol previously reported for siRNA 
experiments. About the concentrations, different doses 
of AnstMO_ABCG4 (0.051 μg/μl; 0.101 μg/μl; 0.203 μg/
μl; 0.406 μg/μl) were tested, in order to evaluate the nec-
essary concentration to obtain the downregulation effect 
in larvae, through oral feeding. This pre-test (results not 
shown) led to the definition of two efficient concentra-
tions, 0.203  μg/μl; 0.406  μg/μl. Following the previous 
protocol, groups of 50 third instar larvae were soaked 
for 3  h in a volume of 357  μl of RNase-free water plus 
AnstMO_ABCG4 at 0.203 μg/μl or 0.406 μg/μl. Control 
groups were treated only with RNase-free water. Thereaf-
ter, each group of larvae was treated, for 6 and 24 h, with 
the  LD20 dose (0.030  mg/l) of permethrin in 100  ml of 
well water. The experiment was performed in three times.
Gene expression analysis in larvae treated 
with Morpholino
Pools of five surviving larvae were collected at six and 
24 h and soaked in extraction buffer + β-mercaptoethanol 
for RNA extraction. The analyses of gene expression were 
carried out following the previously described procedure.
Mortality bioassay on larvae treated with Morpholino
Mortality bioassay was performed to evaluate the phe-
notypic effect on larvae treated with the combination of 
permethrin and Vivo-Morpholino. The same protocol 
described for the siRNA-bioassays was applied using the 
AnstMO_ABCG4 at two concentrations, 0.203 μg/μl and 
0.406 μg/μl.
Statistical analysis
In the bioassays (after six and 24 h) effects of previously 
described treatments on mosquitoes’ mortality and 
ABCG4 gene expression levels were compared by a one-
way ANOVA; when analysis of variance resulted statis-
tically significant (p < 0.05), post hoc comparisons were 
performed by Least Significance Difference (LSD). All 
analyses were implemented using the SPSS software (ver-
sion 20.0; SPSS, Chicago, Illinois).
Results
Bioassays on larvae after siRNA treatment
After determination of the  LD50 of permethrin 
(0.072 mg/l at 24 h), the mortality of larvae was assessed 
at six and 24 h. Using the  LD50 concentration, permethrin 
treatment induced a 12.8 ± 5.21% (mean ± SD) mortal-
ity after 6  h; when administered following the 0.03- or 
0.06-μg/μl siRNA treatments, a 21.6 ± 4.6% or 20 ± 9.38% 
mortality was observed, respectively. A similar pattern 
was observed after 24 h, where permethrin alone led to 
a 45.6 ± 13.45% mortality, increased to 64 ± 10.58% and 
58.4 ± 13.45% by siRNA pre-treatments (at the 0.03- and 
0.06- μg/μl concentrations). The differences between the 
treatment with permethrin alone and those added with 
the lowest concentration of siRNA were statistically sig-
nificant at both time points (LSD test p = 0.027 after 6 h 
p = 0.024 after 24  h). Moreover, at 24  h the difference 
in the efficacy of the scrambled siRNA compared with 
the gene specific siRNA was also statistical significance 
(LSD test p = 0.003 in comparison to 0.03  μg/μl siRNA; 
p = 0.013 in comparison to 0.06 μg/μl and siRNA) even, 
at both concentrations (Fig. 1).
No statistical differences were observed between the 
permethrin alone treatment and those with the two 
doses of scrambled siRNAs (0.03  μg/μl and 0.06  μg/
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μl) (respectively p = 0.422 and p = 0.901 after 6  h; both 
p = 0.219 after 24 h) (Fig. 1).
ABCG4 relative expression in larvae after siRNA treatment
The relative expression of ABC4 transporter was assessed 
through qRT-PCR on larvae exposed to the  LD50 of 
permethrin, alone or in combination with siRNAs and 
scrambled siRNAs, After 6 h, permethrin induced an up-
regulation of ABCG4 of 17.56 ± 1.04-fold, while pretreat-
ment with siRNA, at the two concentrations, led to an 
up-regulation of only 3.08 ± 0.94 and 3.76 ± 1.34 respec-
tively, when compared with control. In other words, a 
“downregulation”, compared to the insecticide alone, of 
15- or 13-folds, respectively, for the 0.03  μg/μl and for 
0.06  μg/μl siRNA pre-treatments, have been observed. 
Post hoc LSD test showed that permethrin treated lar-
vae did not significantly differ in ABCG4 expression 
compared with those treated with scramble siRNA 
(15.67 ± 3.83 and 11.17 ± 1.94 fold), while a significant 
difference was observed with the two siRNA concen-
trations (p = 0.005 for the higher and p = 0.008 for the 
lower concentration). Whereas the two concentrations of 
siRNA did not show a statistically significant difference 
between them (Fig. 2a).
After 24 h, the insecticide induced an up-regulation of 
9.01 ± 1.43-fold in permethrin-treated larvae compared 
Fig. 1 Larval mortality rates in siRNA bioassays. Mortality obtained after 6 h (a) and 24 h (b) of  LD50 permethrin exposure in silenced and 
non-silenced larvae of An. stephensi, through two different concentrations of siRNA (0.03 μg/μl and 0.06 μg/μl). Data were compiled from three time 
replicate experiments and assessed by one-way ANOVA with Post-Hoc LSD test as multiple comparison test. p < 0.05 in comparison to permethrin 
treated larvae; error bars denote standard deviation of the means (SD)
Fig. 2 ABCG4 relative expression after siRNA and permethrin treatments. ABCG4 induction after 6 h (a) and 24 h (b) of  LD50 permethrin exposure 
in silenced and non-silenced larvae of An. stephensi, through two different concentrations of siRNA (0.03 μg/μl and 0.06 μg/μl). Data were compiled 
from three time replicate experiments and assessed by one-way ANOVA with Post-Hoc LSD test, as multiple comparison test. p < 0.01 in comparison 
to permethrin treated larvae (a); p < 0.05 in comparison to permethrin treated larvae (b); error bars denote standard deviation of the means (SD)
Page 6 of 12Negri et al. Malar J          (2019) 18:294 
to the controls. Permethrin in combination with the two 
siRNA concentrations led to a reduced up-regulation, 
of 3.27 ± 1.83 and 3.34 ± 1.76-fold respectively for the 
lower and higher concentrations, compared to control. 
In other words, pre-treatments with siRNA in addition 
to the insecticide showed a down-regulation of 5.74- and 
5.67- fold for the lower and higher concentrations, when 
compared with insecticide-alone treatment (Fig. 2b). The 
post hoc LSD test highlighted no significant differences 
between ABCG4 expression in permethrin-treated larvae 
compared to those treated with scramble siRNA (which 
showed a 6.81 ± 1.75 and 6.86 ± 0.68-fold expressions 
relative to control). On the other hand, a significant dif-
ference was detectable with the two siRNA concentra-
tions, also at the 24 h time point (p = 0.028 and p = 0.035 
respectively for the lower and higher concentrations). No 
statistically significant difference was detected between 
the two concentrations of siRNA.
Systemic siRNA diffusion in Anopheles stephensi larvae
Third instar larvae were exposed to the 0.06  μg/μl con-
centration of the fluorescent siRNA (Alexa fluor 488) 
for 3 h to allow them to up-take the molecule. Figure 3 
shows that, after 3 h of exposure, fluorescence is localized 
mainly in the gut, in the central part of the larval body 
(Fig.  3b), coherently with the assumption that siRNA 
molecule is acquired by the larvae through the oral 
route. The fluorescence emission is much more evident 
in the treated larvae compared to the controls (Fig. 3a), 
in which the emission can be interpreted as auto-fluo-
rescence. After the 3  h of exposure, larvae were moved 
into fresh water for 24 h and then analysed. In this case 
the fluorescent signal is detectable in all the tissues of the 
specimens (Fig. 3c).
Bioassays on larvae after Vivo‑MO treatment
Figure 4 shows the results of the in Vivo-MO bioassays, 
that were effected with a sub-lethal dose of permethrin 
 (LD20). In groups of larvae treated with Vivo-MO alone, 
the oligonucleotides, at the two concentrations, did not 
affect the larval survival: at both time points and at both 
concentrations mortality was equal to that of the con-
trols (0% at 6  h and 1.33 ± 2.3% at 24  h). In contrast, 
treatment with Vivo-MO combined with permethrin 
led to an increase in larval susceptibility, with a dose-
dependent effect that raise over time. At 6  h (Fig.  4a), 
larval mortality with permethrin alone was only 2 ± 2.3% 
(mean ± SD); after exposure to the two concentrations 
of Vivo-MO, 0.203  μg/μl, and 0.406  μg/μl, permethrin-
determined mortality increased up to 6.67 ± 7.88% and 
18.33 ± 6.26%. At 24 h (Fig. 4b), a fortiori, the 22 ± 8.33% 
mortality, determined by the sub-lethal treatment with 
insecticide alone, increased up to 34.67 ± 13.89% with the 
lowest dose of Vivo-MO, and reached the 51.67 ± 15.95% 
with the highest dose. Therefore, at 24 h, an increase in 
the mortality rate of 13% was achieved with 0.203 μg/μl 
of Vivo-MO, and an increase of 30% with 0.406 μg/μl of 
Vivo-MO. The post hoc LSD test showed a statistically 
significant difference (p = 0.0032 after 6  h; p = 0.0006 
after 24 h) between the permethrin treatment alone and 
the one with the highest dose of Vivo-MO at both time 
points.
ABCG4 relative expression analysis in larvae after Vivo‑MO 
treatments
Gene expression analysis was performed through qRT-
PCR on groups of larvae, after six and 24 h of treatment 
with or without Vivo-MO, followed by the treatment 
with  LD20 dose of permethrin (except for Vivo-MO alone 
treatment) (Fig. 5). Considering the mechanism of action 
of Morpholinos, the molecule binds/inhibits a specific 
target mRNA sequence, without degrading it, and so 
it could even induce an ABCG4 upregulation, being a 
xenobiotic compound, instead of a downregulation. At 
6  h the relative expression of ABCG4, compared to the 
control, showed a lower value for larvae treated with per-
methrin alone, of 3.38 ± 1.7, than larvae treated with the 
Fig. 3 Fluorescence emission in siRNA (Alexa Fluor 488) bioassays. 
Third instar larvae of An. stephensi exposed to a 0.06 μg/μl 
concentration of a fluorescent siRNA. a Control larva with slight 
autofluorescence. b Larva after 3 h of exposure to the siRNA; the 
fluorescence is concentrated at the gut level. c Larva exposed for 3 h 
to the siRNA and transferred for 24 h in water. The signal is diffused to 
the whole body
Page 7 of 12Negri et al. Malar J          (2019) 18:294 
combination of insecticide plus Vivo-MO at 0.203  μg/
μl and 0.406  μg/μl, with values of 7.38 ± 2.04 and 
23.97 ± 6.81 respectively. The target gene after inhibition 
with MO oligonucleotides, in fact, was up-regulated 4.00 
fold more than permethrin alone, by the lowest concen-
tration of oligonucleotides, and 20.59 fold by the highest 
concentration. On the contrary, the ABCG4 expression 
in the treatments with Vivo-MO alone (of 1.25 ± 0.17 
fold with 0.203 μg/μl and 2.40 ± 1.40 fold with 0.406 μg/
μl) is lower than those of treatment with inhibitor plus 
insecticide, and that of treatment with permethrin alone. 
Using the post hoc LSD test it was possible to detect the 
differences in relative expression for all treatments. A sta-
tistically significant difference was observed between the 
expression induced by 0.406 μg/μl Vivo-MO (p = 0.0006) 
and that of all other treatments, including the perme-
thrin-alone treatment and the 0.203  μg/μl Vivo-MO 
treatment.
The expression levels didn’t face evident changes 
from six to 24  h: at 24  h the higher dose of Vivo-MO 
caused a slight decrease of ABCG4 expression (not 
statistically significant), perhaps due to the weaken-
ing of cellular defenses over time. Relative expression 
of permethrin was of 4.25 ± 1.72 fold, compared to 
Fig. 4 Larval mortality (%) in Vivo-MO bioassays. After 6 h (a) and 24 h (b) of  LD20 permethrin exposure in silenced and non-silenced larvae of An. 
stephensi, through two different concentrations of Vivo-MO (20 μM = 0.203 μg/μl and 40 μM = 0.406 μg/μl). Data were compiled from three time 
replicate experiments and assessed by one-way ANOVA with Post-Hoc LSD test, as multiple comparison test; p < 0.01 and p < 0.001 in comparison to 
permethrin treated larvae; error bars denote standard deviation of the means (SD)
Fig. 5 ABCG4 relative expression after Vivo-MO and permethrin treatments. ABCG4 induction after 6 h (a) and 24 h (b) of  LD20 permethrin exposure 
in silenced and non-silenced larvae of An. stephensi, through two different concentrations of Vivo-MO (20 μM = 0.203 μg/μl and 40 μM = 0.406 μg/
μl). Data were compiled from three time replicate experiments and assessed by one-way ANOVA with Post-Hoc LSD test, as multiple comparison 
test. p < 0.001 in comparison to permethrin treated larvae; error bars denote standard deviation of the means (SD)
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permethrin in combination with Vivo-MO at lowest con-
centration, (9.07 ± 2.26) and at the highest concentration 
(19.04 ± 8.43). This highlights an up-regulation of 4.82 
and 14.79 respectively, when compared with insecti-
cide alone treatment. The multiple comparisons analysis 
showed that permethrin treatment did not differ from 
those with Vivo-MO alone (p = 0.355 with the low con-
centration; p = 0.609 with the high concentration), while 
a significant difference was obtained with the combina-
tion of insecticide plus the higher concentrations of Vivo-
MO [LSD tests (p = 0.0007)].
Discussion
As for our results about the RNAi, the expression analy-
sis on the whole larval body are consistent with the data 
from previous studies, showing that the peak of ABCG4 
over-expression occurs after 6  h of exposure to perme-
thrin [26]. This transporter was chosen as a target for 
silencing because it demonstrated a strong up-regulation 
among the ABC transporters in An. stephensi in response 
to permethrin treatment, suggesting its involvement in 
the detoxification against this insecticide [22, 25, 26]. 
RNAi-based assays were thus performed to confirm 
this hypothesis, thus to assess whether the inhibition 
of ABCG4 has an effect on mosquito mortality, using 
two siRNA concentrations. At both concentrations, at 
0.03  μg/μl and 0.06  μg/μl, siRNAs were able to induce 
an increased mortality at the two examined time-points 
(Fig. 1). This increase is correlated with the RNAi efficacy 
in down-regulating the expression of ABCG4 at both 
time points at both concentrations (Fig. 2). In this study, 
a detectable down-regulation using both the 0.03  μg/μl 
and the 0.06 μg/μl doses was achieved. In particular, after 
24  h a down-regulation of around 5.74-fold, compared 
with insecticide-alone treatment, was achieved with 
the lower concentration; this downregulation in gene 
expression was associated with an almost 20% mortality 
increase. These obtained results are consistent with stud-
ies where RNAi targeted on efflux pumps and G-protein-
coupled receptor of insecticide resistant larvae of Aedes 
aegypti and Culex quinquefasciatus induced an increased 
toxicity, respectively, of temephos and permethrin [14, 
52, 53]. These results, and those of the current study, are 
also coherent with another work on the diamondback 
moth Plutella xylostella, where the silencing of another 
ABC transporter, ABCH1 (structurally similar to ABCG 
sub-family members), led to larval and pupal lethal 
phenotypes when exposed to the Cry toxin of Bacillus 
turingiensis [54]. By comparing the results obtained at 
the two times and at the two concentrations, the increase 
in larval mortality was not correlated with the dose of 
siRNA used or with the duration of insecticide exposure 
(Fig. 2). It is thus possible that at 6 h of exposure, with the 
0.03 μg/μl siRNA dosage, a plateau effect is achieved.
With the prospect of applying gene silencing tools in 
the field, for the control of mosquito larvae, an impor-
tant issue to be addressed is the method of delivery of 
interfering/downregulating molecules. The results using 
siRNA show that the administration in water, and thus 
the acquisition of the molecule via oral feeding, work 
successfully on An. stephensi larvae, as previously shown 
for other mosquito species [31] as well as for insect spe-
cies belonging to different orders [55]. Despite this, the 
possible factors that could affect the downregulation 
and, therefore, the achievement of a high level of larval 
mortality, remain to be clarified. The efficiency of RNAi 
is highly variable in insect species and in different con-
ditions: the critical factors that determine the ability of 
the target organism to uptake the oligonucleotides, its 
spread to tissues and cells, the activation of an autono-
mous RNAi machinery for mRNA degradation should 
specifically be investigated in the different species [56]. 
Moreover, the critical factors related to the molecule, e.g. 
its stability and integrity in the environment and in the 
larval gut lumen, needed to guarantee the cellular deliv-
ery of a sufficient amount of intact siRNA, have not yet 
been investigated in detail [40]. For example, about host-
related factors, recent studies suggested that Diptera lack 
the transmembrane channel-mediated uptake mecha-
nism, formed by the RNA channel transporters SID-1 
and SID-2, that are involved in siRNA uptake in the gut 
lumen of other insects [55, 57–60]. Despite this, the 
results with fluorescent siRNA demonstrate that this type 
of molecule actually diffuses into the larval mosquito 
body, possibly through an endocytosis-mediated mech-
anism, as suggested in other studies on larvae of Aedes 
aegypti and Anopheles gambiae, that demonstrated the 
spread of the RNAi effects, after oral administration, to 
tissues outside the gut [30, 31]. Anyway, the clear down-
regulation of ABCG4 expression in response to siRNA, 
observed at both six and 24  h of permethrin treatment 
(for both concentrations used), indicates that the mole-
cule actually reaches mosquito cells, activating the degra-
dation of target mRNA also in An. stephensi larvae.
Evidence for a systemic RNAi in dipterans has already 
been obtained in other studies which indicated an effi-
cient internalization and biodistribution of dsRNA in 
An. gambiae cultured cells [61], and a strong RNAi effect 
throughout the development of mosquitoes in Aedes 
aegypti larvae, after feeding [34]. Aspects that are still to 
be clarified regarding the actual amount of siRNA that 
reaches larval tissues, after the administration through 
the breeding water, with the various possible “challenges”, 
such as pH of the water and gut lumen, and the poten-
tially variable conditions of the gut lumen of larvae in 
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field conditions [40]. The exposure of oligonucleotides 
to these challenges, as noted in different reports [31, 
62], implies that oral feeding-based delivery of interfer-
ing RNA molecules determines a less effective knock-
down compared to microinjection-based administration. 
On the other hand, oral administration of siRNA is less 
time-consuming than microinjection, and more suitable 
for high-throughput screenings. In addition, it is likely 
the sole possible way of delivery for field applications for 
mosquito control.
Recently, to achieve the oral administration of RNAi-
inducing molecules to be tested as biopesticides, different 
approaches have been developed with the aim of deliv-
ering intact dsRNAs/siRNAs into cells [63]. The study 
of abiotic and biotic transport methods was designed to 
prevent the degradation of RNA molecules, more fre-
quently in the field settings than in lab conditions [64, 
65]. Liposomes were tested as abiotic carriers [66, 67], 
as well as hydrogel- [61], carbon quantum dot- [68] and 
chitosan-nanoparticles [35, 69]; the last ones, for exam-
ple, are currently considered as the most economical and 
environmentally safe system for the delivery of dsRNAs 
to insect larvae [64, 70]. On the other side, the alternative 
biotic delivery was achieved through the Escherichia coli 
and the Pichia pastoris expression systems, for a cheaper 
large-scale administration of RNAi inducing molecules to 
third instar larvae of mosquitoes [71, 72].
Among the antisense gene knockdown technologies, 
antisense Morpholinos (MOs) present characteristics 
that should guarantee key advantages for future field 
applications. They can ensure highly specific antisense 
activity, and are able to bind the target RNA sequence 
having less interaction with unintended mRNAs, com-
pared with knocking-down RNAi methods based on 
protein/catalytic activity (e.g. siRNA). Their stability is 
due to their molecular structure, and to the covalently 
linked delivery moiety, that make them more durable 
in water, and more easily internalized by intestinal cells 
[42]. Moreover, their lack of electrostatic charge (neutral 
charge) minimizes the interaction with proteins, hence 
implying a reduced toxicity and immunogenicity; at the 
same time, being chemically different from a “normal” 
DNA or RNA molecules, they are resistant to nucleases, 
which implies a higher stability [39, 42].
The results here obtained showed an increased sus-
ceptibility to permethrin after Vivo-MO treatment, con-
gruent with the results obtained using siRNA; the role 
of the ABCG4 transporter in permethrin detoxification 
in An. stephensi is thus further supported. The addition 
of Vivo-MO to the  LD20 dose of permethrin led to a sig-
nificant increase of larval susceptibility, until reaching 
a 50% mortality at the second time point. In particular, 
after 24 h, the 0.406 μg/μl Vivo-MO dose determined an 
increase in larval mortality of 30% compared to perme-
thrin alone, while the 0.203 μg/μl dose, at the same time, 
determined an increase in mortality of 13% (Fig. 4b). The 
reached effect appears dose- and time-dependent, with 
mortality of the two increasing doses shifting from 10 to 
23% at 6 h and from 35 to 52% at 24 h. As shown by our 
results, administration of Vivo-MO in absence of perme-
thrin did not cause any detectable/significant effect in 
term of mortality and ABG4 gene expression. It could be 
concluded that the molecule is non toxic if administered 
alone: its effects were detrimental to mosquito larvae 
when administered with permethrin. This feature has pri-
mary importance to avoid negative effects on non-target 
organisms: specifically-designed Vivo-MO should have 
no effects on non-target species.
As for the relative expression of ABCG4 gene (Fig. 5a, 
b), Vivo-MOs act differently from siRNAs, making mRNA 
unavailable for translation, but without degrading it: 
mRNA molecules, bounded and inhibited by the oligonu-
cleotides, likely accumulate inside the cell without being 
used [38]. It was actually observed that ABCG4 mRNA 
amount increased after combined permethrin-Vivo-MO 
treatment (Fig.  4a, b), while siRNA-permethrin treat-
ment lead to a reduction in ABG4 mRNA content in the 
larvae (Fig. 2a, b). It is possible to suggest that, after the 
permethrin + Vivo-MO treatment, the larval organism is 
increasingly stimulated to produce ABCG4 transporter 
to expel the insecticide, but the mRNA overproduced has 
no effect, as it has been seen from the mortality results 
(Fig. 3a, b): the more Vivo-MO molecules bind the target 
mRNA, making it inactive, the greater the production of 
mRNA. The expression of ABCG4 gene, as can be seen 
from the comparison between the two time points, with 
the two concentrations of Vivo-MO, is stable (expression 
at six and 24 h is not different), but is dose-dependent, i.e. 
with the higher dose of Vivo-MO the amount of mRNA 
detected is higher. It is thus possible that the adminis-
tration of a higher dose of Vivo-MO in the presence of 
the same dose of permethrin would lead to an increased 
larval susceptibility to permethrin. However, the possibil-
ity that inhibition of ABCG4 could lead to the activation 
of other defensome genes responsible for detoxification 
processes and cellular defence (an issue worth of further 
investigations [17, 22]), should be considered. Due to the 
lack of ad-hoc antibody against the ABCG4 of mosqui-
toes (or other insects), quantification of its expression at 
the protein level is challenging. Therefore, or goal was to 
determine the effect of this nucleotide on larval mortality 
(a sort of phenotypic effect). In future studies, it would 
also be interesting to design a scramble Vivo-MO con-
trol, not complementary to the target gene, in order to 
assess whether the phenotypic effect is really due to the 
lack of the transporter or to any other phenomena. For 
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example, in previous studies, it has been shown that per-
methrin can strongly interact with nucleic acids, interca-
lating DNA bases (it is prone to bind to G-C base pairs) 
[73]. One might thus suggest that the effects that were 
recorded could have partially been determined by this, or 
similar, effects of Vivo-MOs.
In the wild, mosquito larvae are exposed to the residues 
of insecticides used in agriculture or in the control of 
adults, where these residues flow to the breeding sites [7]. 
These low amounts of insecticides, creating a toxic stress, 
could induce tolerance by the upregulation of genes 
involved in the xenobiotic metabolism/detoxification 
of chemicals [74, 75]. Notably, this low dose insecticide 
exposition is regarded as one of the major causes for the 
onset of resistant forms in mosquitoes [76, 77]. Consid-
ering the above phenomenon, it was decided to perform 
Vivo-MO assays using a low permethrin dosage  (LD20), 
which might represent a condition present in breeding 
sites in treated areas.
Since prior to this study no bioassays had been car-
ried out with Vivo-MO on mosquito larvae, the doses 
and the timing of administration applied in this study 
represent a first methodological reference for antisense 
MO application through direct feeding in mosquito lar-
val stages. It will certainly be interesting to verify in the 
future if a higher dose of the molecule could lead to a 
further increase in the susceptibility to permethrin. The 
possibility to prolong the knocking-down with sequential 
Vivo-MO treatments against the same ABC transporter 
should be tested, as well as a multiple knockdown target-
ing different detoxification genes, in order to avoid that 
the MO effect declines over time, or to block compensa-
tory effects [41].
Conclusion
In this study, the effects of two different types of mRNA-
targeting oligonucleotides, designed to inhibit the expres-
sion of the defensome gene ABCG4, and administered 
through oral delivery in water, were determined on larvae 
of An. stephensi. The obtained results shown that, target-
ing ABCG4 gene for silencing through both techniques 
resulted in an increased pyrethroid efficacy. In conclu-
sion, these results open the way toward the possibility to 
exploit the inhibition of this gene in the context of inte-
grated programmes for the control of An. stephensi mos-
quitoes and thus malaria transmission. Of course, prior 
to field application, several issues should be addressed. 
First, the potential effects on non-target organisms, start-
ing with in silico studies on the specificity of siRNA or 
Vivo-MO oligonucleotides, but also addressing their 
potential “side effects” not related with mRNA targeting. 
Secondly, the stability and methods of delivery of these 
molecules in field conditions. Finally, field application 
would obviously require a cost-effective method for pro-
duction of the oligonucleotides.
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